-+ 0.00%
-+ 0.00%
-+ 0.00%

Apellis Pharmaceuticals Price Target Raised to $40.00/Share From $39.00 by Cantor Fitzgerald

Dow Jones·08/01/2025 14:20:00

Please log in to view news